Tobacco regulation, litigation, and campaigns.
The four major US regulatory actions proposed since 2009 — nicotine standard, menthol ban, Tobacco 21, graphic warnings — and exactly where each one sits.
9 pieces in this section
2017 → 2025 · the proposal
The FDA's proposed nicotine product standard has been in motion since July 2017. As of early 2025, it has not cleared the rulemaking finish line.
2022 → 2024 · one like it, stopped
The FDA's menthol rule made it to the Federal Register. It did not make it to the Code of Federal Regulations.
The document on the left, the public answer on the right — the pairing this site is built on.
A spending bill signed on 20 December 2019 quietly raised the federal minimum purchase age for tobacco from 18 to 21 — wiping out a patchwork of state laws overnight.
The regulation that finally brought e-cigarettes, cigars, and hookah tobacco under federal law arrived in May 2016 — then spent years being reshaped by litigation and administrative delay.
The FDA's premarket review process has produced a short list of winners, a high-profile denial that courts immediately complicated, and an enforcement landscape that has not kept pace with the market it was meant to police.
The first modified-risk authorisation the FDA granted, an exclusion order that followed a patent dispute, a withdrawal from the US market, and the route back.
A Senate letter in January 2024, a supply shortage that emptied the shelves, and the premarket framework the pouch category already sat inside.
Pack size, combined health warnings, a menthol phase-out dated to 2020, and a notification route for novel products — in application across the EU from May 2016.
Thirty-four reports spanning six decades, each adding a new layer of documented harm to the public record.
The other sections
Freeze Pops · The Papers · truth® · Tips · the whole archive